MOTS-c test results: how often vials pass lab testing
MOTS-c had the lowest pass rate of the 14 peptides we track: two in three recent samples failed. Here are the numbers and where HHS's October 2026 draft policy leaves it.
Of the last 89 MOTS-c samples with a result in Finnrick's public lab-testing database, 30 passed and 59 failed: 34 percent of MOTS-c test results were a pass. Another 6 came back incomplete and are left out. Finnrick has published 95 MOTS-c tests from 23 sellers since 20 Feb 2026.
MOTS-c is a mitochondrial-derived peptide, encoded by mitochondrial DNA rather than the DNA in the cell nucleus. It was discovered in 2015. Its metabolic biology is interesting in animals, but human trials of injected MOTS-c are minimal, so the benefits people hope for are not demonstrated in people.
The short version
- 34 percent of recent samples passed. 30 passed and 59 failed, of the last 89 with a result.
- It is not FDA-approved. HHS's October 2026 draft policy would let licensed pharmacies compound it on a prescription under strict conditions. It is a draft.
- A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
- We do not name sellers. The numbers describe the market, not any one shop.
MOTS-c test results in numbers
| Measure | MOTS-c |
|---|---|
| Published tests | 95 |
| Sellers with at least one test | 23 |
| First and latest test | 20 Feb 2026 to 2 Nov 2026 |
| Recent results counted | 89 (6 incomplete left out) |
| Passed | 30 |
| Failed | 59 |
| Pass rate | 34% |
| Rank by pass rate | 14 of 14 on our peptide test results page |
Figures from Finnrick's public MOTS-c page, checked on 12 November 2026. They will change as new results come in.
What counts as a pass or a fail
These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.
The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.
Is MOTS-c FDA-approved?
No (see our MOTS-c page). FDA took it out of Category 2 in April 2026, its compounding advisory committee recommended it for the 503A bulks list on 23 July 2026 (what that vote means), and HHS's draft enforcement discretion policy of 30 October 2026 covers it. Pharmacies would need a prescription, a registered source and a valid certificate of analysis. It is a draft, and it does not cover research-use-only products.
The lowest pass rate of the 14
Of the last 89 MOTS-c samples with a result, only 30 passed and 59 failed. That is the worst of the 14 compounds on our peptide test results page. Testing is also recent: Finnrick has published 95 MOTS-c tests from 23 sellers, all since 20 Feb 2026.
The sample is smaller than for the big compounds, so the exact figure will move. The direction is hard to argue with.
Before you buy MOTS-c
There is no approved MOTS-c product, and the pharmacy route in the HHS draft does not exist until the policy is final.
Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.
Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.
Questions people ask
What percentage of MOTS-c fails lab testing?
In Finnrick's public test database, 59 of the last 89 MOTS-c samples with a result failed, which is 66 percent, and 30 passed. Tests that came back incomplete are left out.
Is MOTS-c FDA-approved?
It is not FDA-approved. HHS's October 2026 draft policy would let licensed pharmacies compound it on a prescription under strict conditions. It is a draft.
Does a passing lab test mean MOTS-c is safe?
No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether MOTS-c is safe or does anything in people.
Why does MOTS-c fail testing so often?
The public results do not say which check each sample failed. What they show is that 59 of the last 89 MOTS-c samples failed on identity, purity or fill, the highest share of the 14 compounds we track.
Sources
- Methodology, Finnrick, accessed 12 November 2026
- MOTS-c product page and public test history, Finnrick, accessed 12 November 2026
- HHS announces interim enforcement discretion for section 503A compounding with certain peptide bulk drug substances, Venable LLP, 6 November 2026
